BREAKING
  /   MEDLINE Q2 NET SALES: $7.7BN, UP 11.6%   /   CEO JIM BOYLE REPORTS ON DISTRIBUTION-CENTER RESPONSE

People / Leadership / Chicago

Jim Boyle and the 27-year job interview

Jim Boyle joined Medline as a sales representative in 1996. Twenty-seven years later, he took charge of the company - bringing a seller’s attention to promises, people and delivery.

Advertisement

A company can spend five years planning a succession and still choose someone who has been preparing for 27. When Jim Boyle became Medline’s chief executive on October 1, 2023, he had already worked there as a sales representative, a trainer, an account manager and a succession of increasingly senior executives. The announcement changed his title. Much of the education had happened long before.

He had joined in San Antonio in 1996. By 2018, his responsibilities reached across commercial functions, operations and logistics. Sales had become a way into understanding the machinery behind the sale. A customer’s agreement was one event; fulfilling it required a much larger cast.

Boyle became the first non-family chief executive of a business founded in 1966 by brothers Jim and Jon Mills. His appointment brought a new surname to a familiar role. The company had chosen an executive whose record stretched across departments, customers and decades of its own history.

A Texas territory, then the machinery behind it

Boyle earned a Bachelor of Science in Industrial Distribution at Texas A&M University. Even the degree sounds as though it would prefer to get on with the work. It names the business of moving things, selling them and understanding the systems that make those activities possible. His first Medline job put him in the field, representing the company in San Antonio.

The roles that followed widened the view. As a trainer, he worked in the part of the organization that develops other salespeople. As a senior account manager, he took on customer relationships. Divisional and senior vice-presidential positions added responsibility across larger pieces of the business. These were different vantage points on the same recurring transaction: someone makes a commitment, and other people have to make it happen.

The later dates make the progression more concrete. He served as senior vice president of sales from 2014 to 2018, then as senior vice president of national field sales in 2018 before becoming executive vice president that year. By the time the CEO appointment came, his brief already included the work of getting orders through an organization rather than simply getting them signed.

1996San AntonioSales representative
2018A wider remitExecutive vice president
2023The handoverChief executive officer
2025A public companyNasdaq: MDLN

The family business chooses an insider

Medline announced the transition in June 2023, with an effective date in October. Charlie Mills would leave the CEO role and become chairman. Andy Mills and Jim Abrams would also step away from their operating positions while remaining on the board. Jim Pigott would become president and chief operating officer alongside Boyle.

The pairing mattered. Pigott had joined as a sales representative in 1992 and later led product divisions, manufacturing and global sourcing. Boyle brought the commercial, operations and logistics remit. Medline was promoting two executives whose experience covered different stretches of the same business. The company described the handover as the conclusion of a five-year succession process.

For Boyle, becoming the first non-family CEO meant accepting stewardship of an organization whose identity predated his arrival by three decades. His appointment statement thanked the Mills family and emphasized continuing to respond quickly to customers and employees. The language promised continuity. The ownership structure and eventual public listing would introduce new expectations around that continuity.

A succession announcement is usually a tidy document. Careers are less tidy, but Boyle’s had given the decision an unusually long internal record. His colleagues had seen him do jobs well below the one he was now being asked to hold.

Trust, with some working parts attached

In June 2025, Boyle appeared with Dan Hurry at a supply-chain council meeting in Mason, Ohio. Hurry was the founder and president of Advantus Health Partners and the supply-chain chief at Bon Secours Mercy Health. Their subject was a commercial relationship that had developed over several years. About 50 distributors, manufacturers and customers were in the audience.

Medline had become a prime vendor for Mercy Health in 2016. After Mercy Health merged with Bon Secours in 2018, the relationship expanded; by 2019, all sites in the combined organization had contracts with Medline. The partnership offered a specific sequence to discuss, rather than an abstract declaration that relationships were important.

“This trust ultimately leads to improved efficiency and reduced costs.”

Jim Boyle, June 2025

Boyle connected trust to the willingness to exchange information and work together on solutions. Hurry emphasized regular, transparent communication. The subjects were ordinary enough: sourcing, inventory, coordinating decisions. Ordinary subjects become expensive when people stop speaking plainly about them.

For an executive whose responsibilities had joined sales to logistics, this was familiar territory. A relationship could open a conversation about a problem before that problem became a surprise. The useful part of trust, in this telling, was what it allowed people to do together.

Jim Boyle, left, standing with Dan Hurry at a June 2025 supply-chain council event
A conversation with a history. Boyle, left, and Dan Hurry at the June 2025 council event. Their organizations’ relationship began years before the presentation. Photo: Medline.

The former trainer returns to the classroom

The following month, Boyle attended the unveiling of Medline’s expanded sales training center in Northfield, Illinois. The new space covered roughly 14,000 square feet, about 50 percent more than the previous area. The former sales trainer was now the CEO at a ribbon-cutting for a place designed to teach the next arrivals.

There were practical changes behind the ceremony. Two large training rooms could accommodate 100 people, compared with 60 before. Twelve breakout rooms replaced three. Training had previously spilled into other parts of the offices; the redesign brought more of it together. The curriculum was changing, too, with a stronger emphasis on listening, understanding customer needs and communicating candidly.

For a salesforce of more than 2,000 professionals at the time, those details involved a problem of repetition. One executive can talk about listening. Thousands of representatives need opportunities to practice it, ask questions and meet the people who can help them solve a customer’s problem.

Boyle’s own employment history gives the occasion a particular resonance. Training was one of the jobs through which he had passed. Now the company he led was enlarging the rooms, the program and the network of people available to those learning the work.

Northfield training center · July 2025
14,000 square feet

Two large training rooms. Twelve breakout rooms. More space to practice the conversations that begin a commercial relationship.

The sale gains another audience

On December 17, 2025, Medline began trading on Nasdaq under the symbol MDLN. Boyle’s employer was approaching its 60th anniversary. His own tenure was approaching 30 years. A business he had known from inside a sales territory now had a daily public share price.

He also had a new audience for explanations. In a CNBC interview on the day of the debut, he described going public as an opportunity to give Medline a wider voice. His prospectus letter presented the listing as a responsibility and committed him to transparency, integrity and a continued focus on customers. Shareholders were being invited into a story whose operating habits he wanted to preserve.

“We believe we must earn the right to serve our customers.”

Jim Boyle, letter to prospective investors

The distinction between company performance and personal accomplishment matters here. Medline’s 2025 net sales reached $28.4 billion, up 11.5 percent. Its net income fell 3.6 percent to approximately $1.2 billion. The business was growing, and profitability faced pressure. Both facts belonged in the account of Boyle’s tenure.

A public listing gives those competing movements a regular appointment in the calendar. Customer retention, investment, costs and execution can all feature in the same conversation. Boyle’s career had brought him responsibility for their intersection; the reporting timetable made the conversation more visible.

A promise meets an interruption

The reporting year that followed included a much more immediate operational test: a fire at Medline’s distribution center in Tracy, California. In the August 2026 results announcement, Boyle said the team had moved quickly to minimize disruption to customers. Reliability was now a matter of responding to a damaged part of the network.

The financial consequences were visible, too. Medline recorded $336 million in fire-related losses before expected insurance recoveries. Second-quarter net income fell 58.3 percent to $139 million, while net sales grew 11.6 percent to $7.7 billion. A sales increase could sit beside a severe operational setback on the same page.

That juxtaposition makes the earlier discussion of trust more concrete. Customers still needed a working supplier while the supplier dealt with its own interruption. The task called on facilities, employees, communication and decisions about where work could move. Boyle’s longstanding emphasis on execution had acquired an event against which people could judge it.

His public account credited the team’s operational resilience. The losses kept the assessment from becoming a frictionless success story. Leading the business meant describing what had been maintained and accounting for what the disruption had cost.

Jim Boyle and Terry Mills presenting senior buyer Samuel Gewargis with a service award at Medline’s Arlington Heights facility
The other side of the organization chart. Boyle and Terry Mills present senior buyer Samuel Gewargis with a service award in Arlington Heights, Illinois. Photograph published December 2025. Photo: Medline.

Thirty years, counted from the inside

In a 2026 anniversary reflection, Boyle noted the coincidence between his own start and Medline’s birthday. He had arrived in 1996, almost exactly when the company turned 30. Now it was 60, and he had been there for half its history. Corporate anniversaries usually invite a look at the archive. His included a substantial portion of his own working life.

That perspective gives his story its scale. A territory in Texas, a training role, customer accounts, larger divisions, logistics, the executive office and a public listing all belong to one continuous career. His responsibility expanded while the name on the employer line stayed the same.

The appealing part of the progression is how much work it places between the beginning and the title. Boyle had time to become familiar with the people behind the company’s promises. As CEO, he is responsible for keeping that familiarity useful when the business grows, when the audience changes and when a part of the network fails. The 27-year preparation ended in 2023. The deliveries continued.